Sohini Das
 "Sohini Das")
Sohini Das
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Page 94 - Sohini Das
Relief for pharma firms as govt starts clearing API imports from China
This comes after a week of economic disruption caused by introducing stringent scrutiny, resulting in shipments originating in China getting held up at Indian ports.
 "Relief for pharma firms as govt starts clearing API imports from China")
Covid-19 crisis: Health care workers may get vaccine after phase 2 trials
Indigenously developed Bharat Biotech's vaccine candidate Covaxin is entering human trials on Wednesday.
 "Covid-19 crisis: Health care workers may get vaccine after phase 2 trials")
Covid-19 crisis: Bharat Biotech's vaccine gets nod for human trials
The SARS-CoV-2 strain was isolated at National Institute of Virology (Pune), an institute under the ICMR, and transferred to Bharat Biotech.
 "Covid-19 crisis: Bharat Biotech's vaccine gets nod for human trials")
Covid-19 crisis: Govt allows PPE exports after prices crash over 65%
Prices of some grades of PPE have crashed by over 65 per cent in the last one and a half months owing to glut in the domestic market.
 "Covid-19 crisis: Govt allows PPE exports after prices crash over 65%")
Mumbai tweaks discharge protocol in bid to free tertiary care beds faster
City's top hospitals say average length of stay for a Covid-19 patient is now around seven days, down 50% from 14-days in the beginning of the pandemic
 "Mumbai tweaks discharge protocol in bid to free tertiary care beds faster")
Sun Pharma to launch its first innovative product for psoriasis in Japan
Nod for Ilumya, a specialty product, would strengthen firm's dermatology portfolio in Japan, but analysts caution that the segment has been witnessing price erosion of late
 "Sun Pharma to launch its first innovative product for psoriasis in Japan")
Hindustan Antibiotics seeks redemption amid rising anti-China sentiments
The firm is charting a turnaround plan by beginning the manufacturing of key bulk drugs that the government has identified under a production-linked incentive (PLI) scheme
 "Hindustan Antibiotics seeks redemption amid rising anti-China sentiments")
Dexamethasone and remdesivir included in Covid-19 treatment protocol
The Ministry of Health and Family Welfare (MoHFW) on Saturday released the updated clinical management protocol for managing Covid-19 cases
 "Dexamethasone and remdesivir included in Covid-19 treatment protocol")
Piramal sells 20% in pharmaceutical business to Carlyle for $490 mn
Carlyle will pick up a 20 per cent stake for $490 million or around Rs 3,700 crore in the pharma subsidiary called Piramal Pharma Ltd
 "Piramal sells 20% in pharmaceutical business to Carlyle for $490 mn")
India's coronavirus drug market set for price war as firms ready launches
Sources say Cipla-BDR's favipiravir will be at least 30 per cent cheaper than Glenmark's price of Rs 103 per tablet. Cipla did not confirm.
 "India's coronavirus drug market set for price war as firms ready launches")
Marico Foundation rewards innovators making a difference in Covid fight
Three products that offer innovative and affordable protective solutions have been selected
 "Marico Foundation rewards innovators making a difference in Covid fight")
Govt mulls faster drug approval process, regulatory system overhaul
The industry, which has been lobbying for faster approvals for quite some time now, says the current pandemic should help expedite the reforms process
 "Govt mulls faster drug approval process, regulatory system overhaul")
Mumbai docs want key drugs made available fast as hospital wards swell up
If patients recover faster, they needn't stay in hospital for 14 days and this could free up beds; Remdesivir and Favipiravir are in the process of being made available in India
 "Mumbai docs want key drugs made available fast as hospital wards swell up")
Trump's focus on local drugs not immediate concern: Indian pharma industry
US is one of the major export destinations for drugmakers in India, accounting for roughly 33 per cent of the country's drug exports
Covid-19 lockdown: After April shock, drug sales improve in May
Till May 15, the overall inventory was 39 days, compared to 43 days in first half of the previous month
 "Covid-19 lockdown: After April shock, drug sales improve in May")
Covid-19: Pune-based drug firm to export favipiravir to 18 countries
Favipiravir is under trial in many countries as a potential treatment for Covid-19
 "Covid-19: Pune-based drug firm to export favipiravir to 18 countries")
Govt may consider expanding Jan Aushadhi pathology centres to block level
Private diagnostic players' business has been hit due to lockdown; open to PPP
 "Govt may consider expanding Jan Aushadhi pathology centres to block level")
Huge scope for Indian pharma as FDA eases drug scrutiny over shortage in US
Injectibles account for 60% of crunch; most plants under American regulator's lens the past two months have now received positive outcomes
 "Huge scope for Indian pharma as FDA eases drug scrutiny over shortage in US")
How Covid-19 gave a push to domestic med tech manufacturing industry
From PPEs to ventilators to face shields, manufacturers have invested money to ramp up production and deliver during this crisis
 "How Covid-19 gave a push to domestic med tech manufacturing industry")
Centre keen on testing Gilead's remdesivir to combat coronavirus
The USFDA has recently given an emergency approval to the drug for use on coronavirus patients
